Description

Nazo Baby (oxymetazoline) Nasal Drops 0.1 mg/ml. 8 ml Vial

Ingredients:

Active ingredient: Oxymetazoline hydrochloride 0.1 mg/ml. Other ingredients: benzalkonium chloride, sodium chloride, sodium phosphate, sodium citrate, and purified water.

Dosage:

For infants and children under 6 years: Administer 1-2 drops into each nostril every 10-12 hours, as needed. Do not exceed 2 doses in 24 hours.

Indications:

Nazo Baby Nasal Drops are indicated for the relief of nasal congestion due to colds, allergies, or sinusitis in infants and children.

Contraindications:

Do not use Nazo Baby Nasal Drops if the child is allergic to oxymetazoline or any other ingredients in the product. Consult a healthcare provider before use if the child has heart disease, high blood pressure, thyroid disease, diabetes, or difficulty in urination due to an enlarged prostate gland.

Directions:

1. Tilt the child’s head back slightly.
2. Gently insert the dropper into each nostril and squeeze the bulb to release the drops.
3. Keep the child’s head tilted back for a few seconds to allow the drops to spread in the nasal passages.
4. Wipe the dropper tip clean after each use.

Scientific Evidence:

Oxymetazoline, the active ingredient in Nazo Baby Nasal Drops, is a sympathomimetic agent that works by constricting blood vessels in the nasal passages, leading to decreased swelling and congestion. Studies have shown that oxymetazoline is effective in providing rapid relief from nasal congestion in children without significant systemic absorption, making it a safe option for pediatric use.

Additional Information:

It is important to follow the recommended dosage and not exceed the stated frequency of administration to avoid potential side effects such as rebound congestion or nasal irritation. If symptoms persist for more than 3 days, discontinue use and consult a healthcare professional. Store the product at room temperature and out of reach of children.

Oxymetazoline acts locally on alpha-adrenergic receptors in the nasal mucosa, leading to vasoconstriction and reduced nasal blood flow, which helps alleviate congestion. Compared to oral decongestants, nasal oxymetazoline has a faster onset of action and fewer systemic side effects, making it a preferred choice for nasal congestion in children.

Clinical trials have demonstrated the efficacy and safety of oxymetazoline nasal drops in pediatric populations, showing improvements in nasal airflow and congestion symptoms compared to placebo. The localized action of oxymetazoline minimizes the risk of systemic side effects, making it a well-tolerated option for managing nasal congestion in infants and children.